Modulating circadian rhythms of immune cells may reduce the severity of myocardial infarctions that occur at night.
Demonstrates PRMT9's role in reducing myocardial damage in myocardial infarction by regulating macrophage polarization.
Spontaneous myocardial infarction occurred in 6.8% after PCI vs 3.4% after CABG, significantly predicting cardiovascular mortality (adjHR 9.39) within 5 years.
In patients with diabetes and multivessel disease undergoing PCI, ticagrelor was not noninferior to prasugrel for the composite primary outcome at 1 year (16.6% vs 14.2%; P = .12).
This statement evaluates novel risk prediction models and biomarkers for cardiovascular disease, highlighting their clinical utility and assessment criteria.
This scientific statement explores coronary atherosclerosis risks in cancer patients and survivors, suggesting integrated management approaches.
A randomized clinical trial demonstrates improved sinus rhythm restoration in patients using a handheld device for Valsalva maneuver.
Ablation of atrial fibrillation driver regions in humans resulted in 90% freedom from atrial fibrillation after 2 years of follow-up.
A meta-analysis compares 5-year outcomes of TAVI and SAVR in low- to intermediate-risk patients, indicating SAVR may be superior.
A systematic review assesses survival benefits of guideline-directed therapy in older heart failure patients, suggesting improvements are needed.